Second Annual Sentinel Initiative Public Workshop, 69122 [E9-30971]

Download as PDF 69122 Federal Register / Vol. 74, No. 249 / Wednesday, December 30, 2009 / Notices Committee Name Tentative Date of Meeting(s) Science Advisory Board to NCTR Advisory Committee 10-Digit Information Line Code November 17–18 3014512559 March, May, July, and November dates to be announced 8732110002 Center for Tobacco Tobacco Products Scientific Advisory Committee Dated: December 24, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30973 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Second Annual Sentinel Initiative Public Workshop AGENCY: Food and Drug Administration, HHS. mstockstill on DSKH9S0YB1PROD with NOTICES ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing the following workshop: Second Annual Sentinel Initiative Public Workshop. This 1-day workshop, organized and hosted by the Engelberg Center for Health Care Reform at Brookings, is supported by a grant from FDA. This workshop is intended to communicate the current status and future vision of active medical product surveillance activities and explore stakeholder perspectives on a broad range of issues. The workshop will feature a series of presentations on recently completed FDA contracts to inform various aspects of the development of the Sentinel System; an update on FDA’s ongoing pilot projects in active surveillance of medical product safety; and a discussion of three issues of broad interest: maintaining patient privacy while conducting medical product safety surveillance, developing the Sentinel System as a national resource for medical product safety surveillance for others outside of FDA, and developing a multi-purpose distributed system that can be used to conduct safety surveillance, comparative effectiveness research, product quality assessment and to address other types of public health questions. Date and Time: The workshop will be held on January 11, 2010, from 8:30 a.m. to 4:45 p.m. VerDate Nov<24>2008 19:01 Dec 29, 2009 Jkt 220001 Location: The workshop will be held at Marriott Metro Center at 775 12th Street NW., Washington, DC 20005. Contact: Kayla Garvin, Center for Drug Evaluation and Research, Bldg. 22, rm. 4339, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301– 796–3755, e-mail: Kayla.Garvin@fda.hhs.gov. Registration: To attend the workshop, please register at https://tinyurl.com/ yce6c3z. When registering, provide the following information: Your name, title, company or organization (if applicable), address, phone number, and e-mail address. There is no fee to register for the public workshop and because seating is limited, registration will be on a first-come, first-served basis. A 1-hour lunch break is scheduled; however no food will be provided. There are multiple restaurants within walking distance of the hotel where attendees can purchase lunch. If you need special accommodations due to a disability, please contact Brookings’ event coordinator at 202–797–4391 or by email: sentinelevent@brookings.edu at least 7 days in advance. Transcripts: Please be advised that as soon as a transcript is available, it will be accessible at https://www.fda.gov/ Safety/FDAsSentinelInitiative/ ucm149341.htm. It may be viewed at the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be available in either hardcopy or on CD–ROM, after submission of a Freedom of Information request. Written requests are to be sent to the Division of Freedom of Information (HFI–35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6–30, Rockville, MD 20857. Dated: December 23, 2009. David Horowitz, Assistant Commissioner for Policy. [FR Doc. E9–30971 Filed 12–29–09; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: February 1, 2010. Open: 10:30 a.m. to 11:40 a.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Closed: 11:40 a.m. to 12:40 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD E:\FR\FM\30DEN1.SGM 30DEN1

Agencies

[Federal Register Volume 74, Number 249 (Wednesday, December 30, 2009)]
[Notices]
[Page 69122]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-30971]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]


Second Annual Sentinel Initiative Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
workshop: Second Annual Sentinel Initiative Public Workshop. This 1-day 
workshop, organized and hosted by the Engelberg Center for Health Care 
Reform at Brookings, is supported by a grant from FDA. This workshop is 
intended to communicate the current status and future vision of active 
medical product surveillance activities and explore stakeholder 
perspectives on a broad range of issues. The workshop will feature a 
series of presentations on recently completed FDA contracts to inform 
various aspects of the development of the Sentinel System; an update on 
FDA's ongoing pilot projects in active surveillance of medical product 
safety; and a discussion of three issues of broad interest: maintaining 
patient privacy while conducting medical product safety surveillance, 
developing the Sentinel System as a national resource for medical 
product safety surveillance for others outside of FDA, and developing a 
multi-purpose distributed system that can be used to conduct safety 
surveillance, comparative effectiveness research, product quality 
assessment and to address other types of public health questions.
    Date and Time: The workshop will be held on January 11, 2010, from 
8:30 a.m. to 4:45 p.m.
    Location: The workshop will be held at Marriott Metro Center at 775 
12th Street NW., Washington, DC 20005.
    Contact: Kayla Garvin, Center for Drug Evaluation and Research, 
Bldg. 22, rm. 4339, Food and Drug Administration, 10903 New Hampshire 
Ave., Silver Spring, MD 20903, 301-796-3755, e-mail: 
Kayla.Garvin@fda.hhs.gov.
    Registration: To attend the workshop, please register at https://tinyurl.com/yce6c3z. When registering, provide the following 
information: Your name, title, company or organization (if applicable), 
address, phone number, and e-mail address. There is no fee to register 
for the public workshop and because seating is limited, registration 
will be on a first-come, first-served basis. A 1-hour lunch break is 
scheduled; however no food will be provided. There are multiple 
restaurants within walking distance of the hotel where attendees can 
purchase lunch. If you need special accommodations due to a disability, 
please contact Brookings' event coordinator at 202-797-4391 or by e-
mail: sentinelevent@brookings.edu at least 7 days in advance.
    Transcripts: Please be advised that as soon as a transcript is 
available, it will be accessible at https://www.fda.gov/Safety/FDAsSentinelInitiative/ucm149341.htm. It may be viewed at the Division 
of Dockets Management (HFA-305), Food and Drug Administration, 5630 
Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be 
available in either hardcopy or on CD-ROM, after submission of a 
Freedom of Information request. Written requests are to be sent to the 
Division of Freedom of Information (HFI-35), Office of Management 
Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6-30, 
Rockville, MD 20857.

    Dated: December 23, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-30971 Filed 12-29-09; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.